What's in a name? Embryo's, entities, and ANTities in the stem cell debate

21Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.

Abstract

This paper discusses two proposals to the US President's Council on Bioethics that try to overcome the issue of killing embryos in embryonic stem (ES) cell research and argues that neither of them can hold good as a compromise solution. The author argues that (1) the groups of people for which the compromises are intended neither need nor want the two compromises, (2) the US government and other governments of countries with restrictive regulation on ES cell research have not provided a clear and sound justification to take into account minority views on the protection of human life to such a considerable extent as to constrain the freedom of research in the area of stem cell research, and (3) the best way to deal with these issues is to accept that many people and most governments adopt a gradualist and variable viewpoint on the human embryo which implies that embryos can be sacrificed for good reasons and to try to find other, less constraining, ways to take into account minority views on the embryo. Finally, another more efficient and time and money sparing compromise will be proposed for those who accept IVF, a majority in most societies.

Cite

CITATION STYLE

APA

Devolder, K. (2006). What’s in a name? Embryo’s, entities, and ANTities in the stem cell debate. Journal of Medical Ethics, 32(1), 43–48. https://doi.org/10.1136/jme.2005.012203

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free